TipRanks
Go Ultimate55% OFF

Compare Immunovant (IMVT) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
IMVTImmunovant$29.17$6.03B-10.3417.53%Moderate BuyUnlock the IMVT analyst price target with TipRanks PremiumIMVTUnlock the IMVT top-analyst price target with TipRanks Premium
TGTXTG Therapeutics$61.18$9.36B20.0979.84%Moderate BuyUnlock the TGTX analyst price target with TipRanks PremiumIMVT vs TGTXUnlock the TGTX top-analyst price target with TipRanks Premium
VRDNViridian Therapeutics$24.67$2.79B-6.994.27%Strong BuyUnlock the VRDN analyst price target with TipRanks PremiumIMVT vs VRDNUnlock the VRDN top-analyst price target with TipRanks Premium
AUPHAurinia Pharmaceuticals$16.65$2.22B7.0337.38%Moderate BuyUnlock the AUPH analyst price target with TipRanks PremiumIMVT vs AUPHUnlock the AUPH top-analyst price target with TipRanks Premium
PTGXProtagonist Therapeutics$144.85$9.37B118.9186.06%Strong BuyUnlock the PTGX analyst price target with TipRanks PremiumIMVT vs PTGXUnlock the PTGX top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$126.63$10.81B-34.88106.10%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumIMVT vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
IMVTImmunovant29.175.3922.67%
TGTXTG Therapeutics61.1827.4981.60%
VRDNViridian Therapeutics24.671.526.57%
AUPHAurinia Pharmaceuticals16.653.4826.42%
PTGXProtagonist Therapeutics144.8568.9090.72%
KYMRKymera Therapeutics126.6366.91112.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts